Therasphere Y-90
Ended Awarded Last action
- Contract number
- 36C26225N0045
- Awardee
-
Boston Scientific Corp UEI YWDHHW3DLNQ1
- Awarding agency
-
Veterans Integrated Service Network 22
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- -$60,350
Award facts
- Contract value 0% obligated
- $214,825.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Competed under SAP Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Marlborough, MA 01752, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$8,780 | |
| Funding Only Action | $58,500 | |
| Funding Only Action | -$110,070 | |
| Original award | $275,175 |
About this award
Boston Scientific Corp has been awarded a delivery order valued at $214,825 for TheraSphere Y-90 radiation treatment devices, with an ultimate completion date of September 30, 2025. This firm fixed-price delivery order was issued on October 1, 2024, by Veterans Integrated Service Network 22 (VISN 22) without a small business set-aside. The work will be performed in Marlborough, Massachusetts, Boston Scientific's headquarters location. This delivery order is issued against the company's blanket purchase agreement with the Defense Health Agency for radiation treatment devices, which establishes Boston Scientific as a specialized supplier of Y-90 glass microspheres and related radiopharmaceuticals used in cancer treatment across the federal healthcare enterprise.
The award reflects the Veterans Affairs healthcare system's continued reliance on Boston Scientific's portfolio of advanced medical devices for interventional oncology applications. As a global medical technology leader, Boston Scientific has established itself as a critical supplier to multiple Veterans Integrated Service Networks and the Defense Health Agency, providing specialized radiation oncology equipment and devices essential to cancer care delivery across military healthcare facilities and VA medical centers. The TheraSphere product line represents a key therapeutic offering within the company's comprehensive federal contract portfolio, which encompasses cardiovascular, diagnostic, and neuromodulation medical technologies serving federal healthcare agencies without competitive restrictions.
Quick answers
Who was awarded contract 36C26225N0045?
36C26225N0045 was awarded to Boston Scientific Corp by Veterans Integrated Service Network 22 (Veterans Health Administration) on October 1, 2024.
How much is contract 36C26225N0045 worth?
The government has obligated -$60,350 on 36C26225N0045. Its current value, with exercised options, is $214,825.
Is contract 36C26225N0045 an order under another contract?
Yes. 36C26225N0045 is a delivery order under 36C26224D0041, an indefinite delivery contract.
Was contract 36C26225N0045 competed?
The extent of competition for 36C26225N0045 was competed under sap.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award